We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$5.88B
AUM Growth
+$303M
Cap. Flow
+$8.85M
Cap. Flow %
0.15%
Top 10 Hldgs %
30.83%
Holding
588
New
56
Increased
268
Reduced
211
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 28.37%
2 Financials 12.57%
3 Consumer Discretionary 9.49%
4 Communication Services 7.57%
5 Healthcare 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
26
Danaher
DHR
$138B
$62.8M 1.07%
316,651
-12,970
-4% -$2.58M
AVGO icon
27
Broadcom
AVGO
$1.76T
$62.2M 1.06%
188,447
-969
-0.5% -$297K
VSLU icon
28
Applied Finance Valuation Large Cap ETF
VSLU
$545M
$61.4M 1.04%
1,437,371
+209,973
+17% +$8.61M
JMEE icon
29
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
$2.82B
$59.4M 1.01%
935,867
+75,929
+9% +$4.69M
APH icon
30
Amphenol
APH
$185B
$53.7M 0.91%
433,716
-9,355
-2% -$1.03M
KLAC icon
31
KLA
KLAC
$222B
$53.2M 0.9%
493,060
-27,490
-5% -$2.56M
HON icon
32
Honeywell
HON
$76.4B
$53.1M 0.9%
267,471
-66,988
-20% -$14M
MUB icon
33
iShares National Muni Bond ETF
MUB
$45.2B
$52.3M 0.89%
490,899
+27,123
+6% +$2.84M
ORCL icon
34
Oracle
ORCL
$339B
$51.2M 0.87%
182,011
-10,175
-5% -$2.59M
SUB icon
35
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$49.3M 0.84%
462,094
+64,271
+16% +$6.86M
TMO icon
36
Thermo Fisher Scientific
TMO
$214B
$48.4M 0.82%
99,793
+4,484
+5% +$2.09M
CME icon
37
CME Group
CME
$95.4B
$46.2M 0.78%
170,880
-421
-0.2% -$115K
JNJ icon
38
Johnson & Johnson
JNJ
$640B
$45.4M 0.77%
244,938
-1,621
-0.7% -$278K
LRCX icon
39
Lam Research
LRCX
$316B
$43.8M 0.74%
326,945
+4,286
+1% +$454K
ACN icon
40
Accenture
ACN
$106B
$43.6M 0.74%
176,950
-26,039
-13% -$6.79M
MA icon
41
Mastercard
MA
$498B
$42.6M 0.72%
74,961
+1,332
+2% +$765K
ADBE icon
42
Adobe
ADBE
$105B
$42.6M 0.72%
120,809
-9,189
-7% -$3.3M
QLTY icon
43
GMO US Quality ETF
QLTY
$4.78B
$42.3M 0.72%
1,168,016
+93,000
+9% +$3.25M
PWR icon
44
Quanta Services
PWR
$84.2B
$41.8M 0.71%
100,982
-786
-0.8% -$306K
BRK.A icon
45
Berkshire Hathaway Class A
BRK.A
$1.1T
$41.5M 0.7%
55
VTEB icon
46
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
$41.4M 0.7%
825,895
-50,337
-6% -$2.47M
QCOM icon
47
Qualcomm
QCOM
$164B
$40.9M 0.7%
245,924
+574
+0.2% +$91K
AZN icon
48
AstraZeneca
AZN
$269B
$40.3M 0.68%
262,626
+25,034
+11% +$3.79M
SPY icon
49
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$40.2M 0.68%
60,370
+2,408
+4% +$1.54M
SPGI icon
50
S&P Global
SPGI
$124B
$38.2M 0.65%
78,559
-1,461
-2% -$782K

Similar funds

Crestwood Advisors Group's Q3 2025 Portfolio in Review

As of Q3 2025, Crestwood Advisors Group held 588 positions worth $5.88B, up 5.4% from $5.58B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Crestwood Advisors Group's Q3 2025 filing shows 56 new, 268 increased, 211 reduced and 16 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 37,010 shares worth $1.89M. The largest sale was iShares Core S&P Total US Stock Market ETF, an estimated $36.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Crestwood Advisors Group's largest Q3 2025 buy was iShares Floating Rate Bond ETF: 37,010 shares worth $1.89M.
  • Crestwood Advisors Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $65.3M increase.
  • Crestwood Advisors Group's biggest Q3 2025 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $36.6M.
  • Crestwood Advisors Group fully exited Blueprint Medicines in Q3 2025, selling an estimated $917K.
  • Crestwood Advisors Group's ten largest holdings make up 31% of its $5.88B portfolio in Q3 2025.
  • Crestwood Advisors Group opened 56 new positions and closed 16 in Q3 2025.
  • Crestwood Advisors Group's portfolio value rose 5.4% quarter-over-quarter to $5.88B.

Based on Crestwood Advisors Group's 13F filing for Q3 2025, filed 7 Nov 2025.